Morgan Stanley’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Morgan Stanley’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$220	–	7851
2022 Q4	$220	Hold	1,000	–	–	﹤0.01%	7635
2022 Q3	$0	Hold	1,000	–	–	﹤0.01%	7927
2022 Q2	$1K	Hold	1,000	–	–	﹤0.01%	7716
2022 Q1	$1K	Hold	1,000	–	–	﹤0.01%	7882
2021 Q4	$2K	Buy	1,000 +800	+400%	+$2.8K	﹤0.01%	7811
2021 Q3	$1K	Hold	200	–	–	﹤0.01%	7815
2021 Q2	$1K	Sell	200 -300	-60%	-$1.11K	﹤0.01%	7643
2021 Q1	$1K	Hold	500	–	–	﹤0.01%	7393
2020 Q4	$1K	Buy	+500	New	+$452	﹤0.01%	6982
2018 Q3	–	Sell	-69	Closed	–	–	6830
2018 Q2	$0	Buy	+69	New	+$34	﹤0.01%	6769

Other funds holding PAVMZ

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley's PAVMZ Position: Q1 2023 in Review

Morgan Stanley sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q1 2023, closing a stake of 1,000 shares — an estimated $220 sold.

Morgan Stanley first reported a position in PAVMZ in Q2 2018 and held it in 10 quarters. The position peaked at $2K in Q4 2021. 7 funds tracked by Wall St. Rank hold PAVMZ as of Q1 2023.

Morgan Stanley reported no remaining PAVmed Inc. Series Z Warrant position as of Q1 2023 after selling out during the quarter.
Morgan Stanley sold 1,000 PAVmed Inc. Series Z Warrant shares in Q1 2023, an estimated $220.
Morgan Stanley first reported a position in PAVmed Inc. Series Z Warrant in Q2 2018 and held it in 10 quarters.
Morgan Stanley's PAVmed Inc. Series Z Warrant position peaked at $2K in Q4 2021.
7 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.